The Indegene Limited IPO witnessed robust demand from investors, with the public issue oversubscribed by over 70 times on its closing day. Subscription figures stood at 7.79 times in the retail category, while Qualified Institutional Buyers (QIB) displayed significant interest at 192.72 times, and Non-Institutional Investors (NII) at 55.83 times.
Offering 2,86,25,450 shares, the IPO garnered bids for 2,01,10,03,830 shares. Allotment of shares is scheduled for May 9. The IPO was priced between Rs 430 and Rs 452 per share, aiming to raise Rs 1,841.76 crore through a combination of fresh share issuance and offer-for-sale (OFS).
The latest Grey Market Premium (GMP) for the Indegene IPO stands at Rs 290 as of May 8, 2024. Considering the price band and GMP, the estimated listing price for the IPO is projected to be Rs 742 per share, indicating a potential gain of 64.16% per share.
Before the IPO launch, Indegene secured Rs 548.78 crore from anchor investors, including prominent names like Smallcap World Fund and Abu Dhabi Investment Authority. The company's listing on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) is scheduled for May 13.
